Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

CA23344H1091
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG00Z3YGPM7
DHT.U
DRI Healthcare Trust
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: - · THEMEFOLIO: $HLTH
NAME
DRI Healthcare Trust
ISIN
CA23344H1091
TICKER
DHT.U
MIC
XTSE
REUTERS
DHT_u.TO
BLOOMBERG
DHT.U CN
Wed, 04.11.2026       DRI Healthcare Trust
CA23344H1091

Normalized Total Cash Receipts and Adjusted EBITDA each grew 9% to $47.5 million and $40.0 million, respectively, with an 84% Adjusted EBITDA marginDRI Healthcare acquired royalty participation rights in Juvmo (tavapadon) for a purchase price of $316M DRI Healthcare exercised its contractual put option on Ekterly for a total net repurchase price o...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Wed, 14.10.2026       DRI Healthcare Trust
CA23344H1091

TORONTO, Oct. 14, 2026 /CNW/ -- DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare"), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its third quarter 2026 financial results on Thursday, November 5, 2026, at 8:00 a.m. ET. DRI Healthca...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Mon, 28.09.2026       DRI Healthcare Trust
CA23344H1091

TORONTO, Sept. 28, 2026 /CNW/ -- DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") today commented on the U.S. Food and Drug Administration's ("FDA") recently announced approval of Juvmo (tavapadon) for the treatment of motor symptoms that occur in Parkinson's disease. Juvmo (tavapadon) is a novel selective dopamine D1/D5 receptor...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Mon, 21.09.2026       DRI Healthcare Trust
CA23344H1091

– DRI Healthcare to acquire royalty participation rights on tavapadon for an aggregate purchase price of US$316 million upon FDA approval of tavapadon –– Tavapadon is a novel oral dopamine-D1R/D5R partial agonist that has been submitted to the FDA for approval for the treatment of Parkinson's disease –– DRI Healthcare to host investor call on Monda...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Tue, 11.08.2026       DRI Healthcare Trust
CA23344H1091

TORONTO, Aug. 11, 2026 /CNW/ -- DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") today announced that it has received the Put Price of approximately US$178 million in connection with its previously announced exercise of the contractual put option with respect to its royalty participation right in EKTERLY (the "Put Option")....
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Fri, 07.08.2026       DRI Healthcare Trust
CA23344H1091

Delivered record second quarter Total income, Total Cash Receipts and Adjusted EBITDADelivered Adjusted EBITDA margin of 92%Subsequent to the end of the quarter, DRI Healthcare exercised its contractual put option on Ekterly for a total net repurchase price of ~$178MTORONTO, Aug. 7, 2026 /CNW/ -- DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("D...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Mon, 20.07.2026       DRI Healthcare Trust
CA23344H1091

TORONTO, July 20, 2026 /CNW/ -- DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare"), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its second quarter 2026 financial results on Monday, August 10, 2026, at 8:00 a.m. ET. DRI Healthcar...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Fri, 10.07.2026       DRI Healthcare Trust
CA23344H1091

TORONTO, July 10, 2026 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) ((TSX: DHT.U) ("DRI Healthcare") today announced that it has exercised its contractual put option (the "Put Option") with respect to DRI Healthcare's royalty participation right in EKTERLY® (sebetralstat) for a total net repurchase price of approximately US$178 million ("Put Price")...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Mon, 29.06.2026       DRI Healthcare Trust
CA23344H1091

- First approved treatment for thyroid eye disease (TED) with labeling that includes data for both active and chronic TED -- DRI Healthcare is entitled to a tiered royalty on annual U.S. net sales of Viridian's TED franchise -TORONTO, June 29, 2026 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") today commented on Viridi...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Fri, 15.05.2026       DRI Healthcare Trust
CA23344H1091

TORONTO, May 15, 2026 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") is pleased to announce results of voting at its annual and special meeting  of unitholders held on May 15, 2026. All of the nominees for election as trustees of DRI Healthcare referred to in its management information circular dated April 13, 2026 were...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Thu, 14.05.2026       DRI Healthcare Trust
CA23344H1091

Delivered record first quarter Total income of $50.6MDelivered Adjusted EBITDA of $52.8M and margin of 90%Successfully issued $250M Senior Secured NotesRepurchased $79.7M of preferred securities in exchange for C$108.7M of convertible debenturesNormal Course Issuer Bid reactivatedTORONTO, May 14, 2026 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TS...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Wed, 29.04.2026       DRI Healthcare Trust
CA23344H1091

TORONTO, April 29, 2026 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") today noted the announcement by KalVista Therapeutics, Inc. ("KalVista"), that it has entered into a definitive agreement to be acquired by Chiesi Group, an international research-focused biopharmaceutical group (the "Transaction")....
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Fri, 24.04.2026       DRI Healthcare Trust
CA23344H1091

TORONTO, April 24, 2026 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare"), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its first quarter 2026 financial results on Friday, May 15, 2026, at 8:00 a.m. ET. DRI Healthcare wi...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Thu, 09.04.2026       DRI Healthcare Trust
CA23344H1091

Toronto, Ontario--(Newsfile Corp. - 9 avril 2026) - Ali Hedayat, chef de la direction, DRI Healthcare Trust (« DRI Healthcare » ou la « société ») (TSX : DHT.UN / DHT.U), et son équipe de direction se sont joints à Dani Lipkin, directeur général, Secteur de l'innovation mondiale, Bourse de Toronto (...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Wed, 25.03.2026       DRI Healthcare Trust
CA23344H1091

TORONTO, March 25, 2026 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") is pleased to announce that its subsidiary, DRI Healthcare LP (the "Issuer"), has successfully closed its previously announced private placement offering consisting of two tranches of senior secured notes (together, the "Notes"):...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Fri, 20.03.2026       DRI Healthcare Trust
CA23344H1091

TORONTO, March 20, 2026 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") is pleased to announce that it has successfully completed the closing of the previously announced private placement offering of convertible unsecured subordinated debentures (the "Debentures") in the aggregate principal amount of C$108,723,000....
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Wed, 04.03.2026       DRI Healthcare Trust
CA23344H1091

Total income of $61.7 million in the fourth quarterAdjusted EBITDA margin of 91% in the fourth quarter; internalization benefits pacing ahead of scheduleDelivered record full year Total income, Total Cash Receipts and Adjusted EBITDACommitted capital over $1.25 billion, including future contingent milestone paymentsReturned over $36 million of cap...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Mon, 02.03.2026       DRI Healthcare Trust
CA23344H1091

– Refinancing extends maturity profile of existing debt by up to two years – TORONTO, March 2, 2026 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") is pleased to announce that it has entered into subscription agreements with EdgePoint Wealth Management Inc., and Alberta Investment Management Corporation (AIMCo), the hold...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Wed, 11.02.2026       DRI Healthcare Trust
CA23344H1091

TORONTO, Feb. 11, 2026 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare"), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its fourth quarter and full year 2025 financial results on Wednesday, March 4, 2026, at 8:00 a.m. ET....
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Wed, 31.12.2025       DRI Healthcare Trust
CA23344H1091

Das Instrument 3IJ0 CA23344H1091 DRI HEALTHCARE TRUST UT EQUITY wird ex Dividende/Zinsen gehandelt am 31.12.2025 The instrument 3IJ0 CA23344H1091 DRI HEALTHCARE TRUST UT EQUITY has its ex-dividend/interest day on 31.12.2025...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Wed, 05.11.2025       DRI Healthcare Trust
CA23344H1091

Subsequent to the end of the quarter, DRI Healthcare acquired a royalty interest in the U.S. net sales of veligrotug and VRDN-003, for up to $300 million Portfolio assets generated Total Income of $48.7 million...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Mon, 20.10.2025       DRI Healthcare Trust
CA23344H1091

–Third synthetic royalty transaction & second pre-approval deal for DRI – – Further increases portfolio exposure to rare diseases ––  Long-dated cashflows, extend portfolio duration –– DRI Healthcare to pay US$55 million upfront; up to US$300 million total investment, subject to achievement...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Thu, 16.10.2025       DRI Healthcare Trust
CA23344H1091

TORONTO, Oct. 16, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare"), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its third quarter 2025 financial results on Thursday, November 6,...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Fri, 19.09.2025       DRI Healthcare Trust
CA23344H1091

TORONTO, Sept. 19, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") is pleased to announce the promotion of Zaheed Mawani to Chief Financial Officer, effective October 1, 2025. Mr. Mawani joined DRI H...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Tue, 16.09.2025       DRI Healthcare Trust
CA23344H1091

TORONTO, Sept. 16, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare"), a global leader in providing financing to advance innovation in the life sciences industry, today announced that it will present at the following investor conferences in September and October:...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Thu, 14.08.2025       DRI Healthcare Trust
CA23344H1091

Subsequent to the end of the quarter, completed the previously announced transaction to internalize its investment management functionPortfolio assets generate Total Income of $44.1 millionReactivated NCIB and repurchased ~958 K units for $9.1 million, while redeeming $10 million of Series C Preferred Securities for $9.5 millionTORONTO, Aug. 13,...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Thu, 24.07.2025       DRI Healthcare Trust
CA23344H1091

TORONTO, July 24, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare"), a global leader in providing financing to advance innovation in the life sciences industry, today announced that it will hold a conference call to discuss its second quarter 2025 financial results on Thursday, August 14, 2025, at 8:00 a.m. ET. The T...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Tue, 08.07.2025       DRI Healthcare Trust
CA23344H1091

– Ekterly is the first and only oral on-demand therapy for treating attacks associated with hereditary angioedema – – DRI Healthcare is entitled to a tiered royalty on worldwide net sales of Ekterly – – KalVista has elected to receive additional funding increasing our total investment to $127 million – TORONTO, July 8, 2025 /CNW/ - DRI Healthcare...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Tue, 01.07.2025       DRI Healthcare Trust
CA23344H1091

TORONTO, July 1, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") today announced that it has completed its previously announced transaction to internalize its investment management function. "We are...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Sat, 14.06.2025       DRI Healthcare Trust
CA23344H1091

- FDA decision anticipated within four weeks - TORONTO, June 13, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") today announced KalVista Pharmaceuticals ("KalVista") has disclosed that it has received notice from the U.S. Food and Drug Administration ("FDA") that the FDA will not meet the June 17, 2025 PDUFA goal date...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Mon, 09.06.2025       DRI Healthcare Trust
CA23344H1091

– Adds extensive expertise in audit, risk and financial strategy – TORONTO, June 9, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced Annalisa King has been appointed as an independent member and chair of the audit committee of the Trust's board of trustees effective immediately....
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Tue, 13.05.2025       DRI Healthcare Trust
CA23344H1091

TORONTO, May 13, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held on May 13, 2025. All of the nominees for election as trustees of the Trust referred to in its management information circular dated March 31, 2025 w...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Mon, 12.05.2025       DRI Healthcare Trust
CA23344H1091

Definitive agreements for internalization transaction entered into with manager, estimated to deliver $200 million in cumulative savings over 10 years1Portfolio assets generate second highest cash receipts and Adjusted EBITDA since IPONormal course issuer bid reactivated with ability to purchase over 3 million unitsTORONTO, May 12, 2025 /CNW/ - D...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Tue, 22.04.2025       DRI Healthcare Trust
CA23344H1091

TORONTO, April 22, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its first quarter 2025 financial results on Tuesday, May 13, 2025, at 8:00 a.m. ET. The Trust will repor...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Wed, 05.03.2025       DRI Healthcare Trust
CA23344H1091

TORONTO, March 5, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN/DHT.U) ("DRI" or "the Trust") today informs its unitholders of an adjustment to its previously announced quarterly cash distribution to unitholders of record as at March 31, 2025. This adjustment is required due to the occurrence of a Canadian statutory holiday on the originally sch...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Mon, 03.03.2025       DRI Healthcare Trust
CA23344H1091

Remediation of material weaknesses complete 45% increase in Normalized Total Cash Receipts over the prior year showcases continued execution and growth of portfolioAnnouncing 2025 royalty income guidance of $172 to $182 million, excluding milestone income and any new transactions, and increase in quarterly distribution to $0.10 per unitTORONTO, M...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Wed, 29.01.2025       DRI Healthcare Trust
CA23344H1091

TORONTO, Jan. 29, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025, at 8:00 a.m. ET. The T...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Fri, 20.12.2024       DRI Healthcare Trust
CA23344H1091

TORONTO, Dec. 20, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announces that in accordance with the requirement for the Trust to distribute all of its taxable income for the year, its Board of Trustees has declared a special...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Wed, 06.11.2024       DRI Healthcare Trust
CA23344H1091

53% adjusted EBITDA growth over prior year period shows strong focus on cash generation Recent acquisitions and credit facility expansion highlight growth under new leadership TORONTO, Nov. 6, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced its financial results for the quarter ended September 3...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Mon, 04.11.2024       DRI Healthcare Trust
CA23344H1091

– First pre-approval royalty acquisition and first equity investment highlight evolving investment strategy – – Up to US$184 million investment brings capital deployment to over US$1 billion since IPO – – Long-term asset in new therapeutic area further increases portfolio duration and diversification – TORONTO, Nov. 4, 2024 /CNW/ - DRI Healthcare...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Fri, 01.11.2024       DRI Healthcare Trust
CA23344H1091

– Enhances deployment capacity without increasing leverage parameters – – Sufficient funding to achieve 2025 deployment target – – Marginal decrease in interest rate and standby fees – TORONTO, Nov. 1, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the li...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Fri, 11.10.2024       DRI Healthcare Trust
CA23344H1091

TORONTO, Oct. 11, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a conference call to discuss its third quarter 2024 financial results on Thursday, November 7, 2024, at 8:00 a.m. ET. The Trust will report its financial results on Wednesday, November 6, 2024, after market close....
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink
Fri, 04.10.2024       DRI Healthcare Trust
CA23344H1091

– Transaction adds another innovative rare disease therapy to the DHT portfolio – – Novel deal structure offers predictable annual cash flows as well as potential additional annual sales-based milestones and a one-time contingent payment – TORONTO, Oct. 3, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") today announced...
Read more
DRI Healthcare Trust
Technical Analysis Termsheets Terminal
Permalink